2m 2m 2m 2m 2m 2m 2m
CHINA PHARMA (CPHI)
NYSE
$0.89+$0.004 (+0.45%)
Price as of Jun 03, 2026 6:09 PM EDT- $32.2MMarket Cap
- -46.70%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
CHINA PHARMA (CPHI)
$0.89+$0.004 (+0.45%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 4.1M -8.49% | 4.5M -35.41% | 7.0M -13.48% | 8.1M -15.95% | |
Cost of Revenue | 4.3M -34.36% | 6.5M -10.67% | 7.3M -15.19% | 8.6M -7.48% | |
Gross Profit | -131,950 -93.35% | -2.0M +606.42% | -281,085 -43.09% | -493,916 -241.41% | |
Sales and Marketing Expense | 375,786 -28.94% | 528,824 -32.23% | 780,328 -27.06% | 1.1M -28.44% | |
Research and Development Expense | -280,901 -1.07% | -283,942 +18.27% | -240,080 +29.17% | -185,858 -41.73% | |
Depreciation and Amortization Expense | 1.5M -42.57% | 2.6M -4.92% | 2.8M +1.97% | 2.7M -12.54% | |
Total Operating Expenses | 3.1M +19.36% | 2.6M +5.36% | 2.5M -19.13% | 3.1M -4.82% | |
Operating Profit | -3.2M -29.41% | -4.6M +66.76% | -2.8M -22.46% | -3.5M +24.07% | |
Interest Income | 2,003 -69.84% | 6,641 +0.59% | 6,602 -38.61% | 10,755 +254.37% | |
Interest Expense | -102,037 -33.80% | -154,140 -53.79% | -333,600 -23.24% | -434,619 -19.81% | |
Interest Income and Expense and Net | -100,034 -32.18% | -147,499 -54.89% | -326,998 -22.85% | -423,864 -21.36% | |
Total Nonoperating Income and Expense | 51,522 +134.93% | -147,499 -54.89% | -326,998 -22.85% | -423,864 -21.36% | |
Income before Taxes | -3.2M -32.70% | -4.7M +53.84% | -3.1M -22.50% | -4.0M +16.87% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -3.2M -32.70% | -4.7M +53.84% | -3.1M -22.50% | -4.0M +16.87% | |
Net Income from Continuing Operations Applicable to Common | -3.2M -32.70% | -4.7M +53.84% | -3.1M -22.50% | -4.0M +16.87% | |
Basic EPS and Net Income | -0.74 +174.07% | -0.27 -70.33% | -0.91 +19.74% | -0.76 +985.71% | |
Diluted EPS and Net Income | -0.74 +174.07% | -0.27 -70.33% | -0.91 +19.74% | -0.76 +985.71% | |
Basic Weighted Average Shares | 4.3M -75.43% | 17.5M +416.13% | 3.4M -35.64% | 5.3M -88.60% | |
Diluted Weighted Average Shares | 4.3M -75.43% | 17.5M +416.13% | 3.4M -35.64% | 5.3M -88.60% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 345,112 -44.95% | 626,879 -55.97% | 1.4M -29.86% | 2.0M -58.22% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 345,112 -44.95% | 626,879 -55.97% | 1.4M -29.86% | 2.0M -58.22% | |
Total Current Assets | 2.3M -28.25% | 3.3M -45.47% | 6.0M +0.54% | 6.0M -34.41% | |
Accumulated Depreciation | 33.5M +4.33% | 32.1M +5.61% | 30.4M +7.21% | 28.4M +0.68% | |
Property and Plant and Equipment and Net | 4.4M -10.06% | 4.9M -31.22% | 7.1M -28.80% | 10.0M -24.90% | |
Total Long-Term Assets | 4.4M -10.06% | 4.9M -31.22% | 7.1M -28.80% | 10.0M -24.90% | |
Total Assets | 31.0M +108.22% | 14.9M -9.60% | 16.5M -7.39% | 17.8M -21.48% | |
Income Taxes Payable | 747,805 +2.27% | 731,202 -1.47% | 742,114 -1.67% | 754,698 -8.46% | |
Total Short-Term Debt | 3.4M +10.06% | 3.1M +57.33% | 2.0M -19.26% | 2.4M -43.61% | |
Total Current Liabilities | 7.4M +47.50% | 5.0M -26.44% | 6.8M -46.46% | 12.7M +21.17% | |
Total Long-Term Debt | 1.8M +25.80% | 1.4M -1.47% | 1.4M -73.11% | 5.3M 0.00% | |
Total Long-Term Liabilities | 1.6M +9.90% | 1.5M -4.05% | 1.5M -1.89% | 1.6M -8.23% | |
Total Liabilities | 8.3M +15.69% | 7.1M -20.80% | 9.0M -33.20% | 13.5M -18.87% | |
Retained Earnings | -47.2M +7.24% | -44.0M +12.05% | -39.3M +8.50% | -36.2M +12.32% | |
Total Stockholders Equity | 22.7M +193.50% | 7.7M +3.93% | 7.5M +73.77% | 4.3M -28.71% | |
Total Shares Outstanding | 15.5M -52.41% | 32.6M +206.98% | 10.6M +41.85% | 7.5M -84.18% | |
Cash Flow | |||||
Cash from Operating Activities | 148,261 +131.79% | -466,362 -33.35% | -699,686 +70.84% | -409,545 +63.92% | |
Capital Expenditures | 59,324 +54.45% | 38,411 N/A | N/A N/A | 401,964 -8.24% | |
Cash from Investing Activities | -137,251 -52.95% | -291,718 +2,432.93% | -11,517 -97.13% | -401,964 -8.24% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -294,027 -1,174.94% | 27,353 -62.60% | 73,145 +104.13% | -1.8M -138.50% | |
Financials Ratio | |||||
Gross Margin | -3.18% -92.74% | -43.84% +993.63% | -4.01% -34.22% | -6.09% -268.25% | |
Operating Margin | -78.16% -22.86% | -101.32% +158.16% | -39.25% -10.38% | -43.79% +47.61% | |
Return on Assets | -13.89% -54.01% | -30.21% +68.05% | -17.98% -8.52% | -19.65% +26.50% | |
Return on Equity | -20.91% -66.44% | -62.31% +18.85% | -52.43% -31.98% | -77.08% +58.98% | |
Revenue Growth | -8.49% -76.01% | -35.41% +162.56% | -13.48% -15.45% | -15.95% +41.53% | |
Current Ratio | 0.32 -51.35% | 0.65 -25.86% | 0.88 +87.78% | 0.47 -45.87% | |
Cash Ratio | 0.05 -62.69% | 0.12 -40.18% | 0.21 +31.07% | 0.16 -65.53% | |
Debt-to-Equity Ratio | 0.23 -60.84% | 0.58 +27.74% | 0.45 -74.69% | 1.79 +12.63% | |
Debt-to-Assets Ratio | 0.17 -44.81% | 0.30 +46.88% | 0.21 -52.51% | 0.43 +2.27% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow